Showing results (441-450 of 2,733) with videos related to

Sort By:
Pageof 274
Pharmacogenomics|June 11, 2013
Association of ABCB1 genetic polymorphisms with susceptibility to colorectal cancer and therapeutic prognosisHuizhe Wu, Hui Kang, Yong Liu, et al.
Pharmacogenomics|June 11, 2013
High-resolution melt analysis to detect sequence variations in highly homologous gene regions: application to CYP2B6Greyson P Twist, Roger Gaedigk, J Steven Leeder, et al.
Pharmacogenomics|June 11, 2013
Role of interactions in pharmacogenetic studies: leukotrienes in asthmaMarc Via, Haig Tcheurekdjian, Esteban González Burchard
Pharmacogenomics|June 11, 2013
Clinical relevance of pharmacogenetics in gastrointestinal stromal tumor treatment in the era of personalized therapySabrina Angelini, Gloria Ravegnini, Jonathan A Fletcher, et al.
Pharmacogenomics|June 11, 2013
Clinical delivery of pharmacogenetic testing services: a proposed partnership between genetic counselors and pharmacistsRachel Mills, Susanne B Haga
Pharmacogenomics|June 11, 2013
Pharmacogenomics of lipid-lowering therapiesMiao Hu, Brian Tomlinson
Pharmacogenomics|November 7, 2013
Effect of genetic variants GSTA1 and CYP39A1 and age on busulfan clearance in pediatric patients undergoing hematopoietic stem cell transplantationMarloes H ten Brink, Tom van Bavel, Jesse J Swen, et al.
Pharmacogenomics|November 7, 2013
EGFR and KRAS mutations, and ALK fusions: current developments and personalized therapies for patients with advanced non-small-cell lung cancerRamon Andrade de Mello, Pedro Madureira, Liliana S Carvalho, et al.
Pharmacogenomics|October 4, 2013
Pharmacogenetics of antiplatelets and anticoagulants: a report on clopidogrel, warfarin and dabigatranStephanie Ross, Guillaume Paré
Pharmacogenomics|October 4, 2013
Polymorphisms in the organic anion transporting polypeptide genes influence liver parenchymal enhancement in gadoxetic acid-enhanced MRIHironao Okubo, Hitoshi Ando, Shigehiro Kokubu, et al.
Pageof 274